185 related articles for article (PubMed ID: 19307184)
41. A small molecule inhibits Akt through direct binding to Akt and preventing Akt membrane translocation.
Kim D; Sun M; He L; Zhou QH; Chen J; Sun XM; Bepler G; Sebti SM; Cheng JQ
J Biol Chem; 2010 Mar; 285(11):8383-94. PubMed ID: 20068047
[TBL] [Abstract][Full Text] [Related]
42. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
[TBL] [Abstract][Full Text] [Related]
43. Domain shuffling as a tool for investigation of protein function: substitution of the cysteine-rich region of Raf kinase and PKC eta for that of yeast Pkc1p.
Schmitz HP; Jöckel J; Block C; Heinisch JJ
J Mol Biol; 2001 Aug; 311(1):1-7. PubMed ID: 11469853
[TBL] [Abstract][Full Text] [Related]
44. Insights into the pathological mechanisms of p85α mutations using a yeast-based phosphatidylinositol 3-kinase model.
Oliver MD; Fernández-Acero T; Luna S; Rodríguez-Escudero I; Molina M; Pulido R; Cid VJ
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28143957
[TBL] [Abstract][Full Text] [Related]
45. Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells.
Gonzalez-Robayna IJ; Falender AE; Ochsner S; Firestone GL; Richards JS
Mol Endocrinol; 2000 Aug; 14(8):1283-300. PubMed ID: 10935551
[TBL] [Abstract][Full Text] [Related]
46. The two isoforms of the Na+/Ca2+ exchanger, NCX1 and NCX3, constitute novel additional targets for the prosurvival action of Akt/protein kinase B pathway.
Formisano L; Saggese M; Secondo A; Sirabella R; Vito P; Valsecchi V; Molinaro P; Di Renzo G; Annunziato L
Mol Pharmacol; 2008 Mar; 73(3):727-37. PubMed ID: 18079274
[TBL] [Abstract][Full Text] [Related]
47. Specific gene expression signatures induced by the multiple oncogenic alterations that occur within the PTEN/PI3K/AKT pathway in lung cancer.
De Marco C; Laudanna C; Rinaldo N; Oliveira DM; Ravo M; Weisz A; Ceccarelli M; Caira E; Rizzuto A; Zoppoli P; Malanga D; Viglietto G
PLoS One; 2017; 12(6):e0178865. PubMed ID: 28662101
[TBL] [Abstract][Full Text] [Related]
48. Insulin-stimulated Interaction between insulin receptor substrate 1 and p85alpha and activation of protein kinase B/Akt require Rab5.
Su X; Lodhi IJ; Saltiel AR; Stahl PD
J Biol Chem; 2006 Sep; 281(38):27982-90. PubMed ID: 16880210
[TBL] [Abstract][Full Text] [Related]
49. Phosphatidylinositol Phosphate 5-Kinase Iγ and Phosphoinositide 3-Kinase/Akt Signaling Couple to Promote Oncogenic Growth.
Thapa N; Choi S; Tan X; Wise T; Anderson RA
J Biol Chem; 2015 Jul; 290(30):18843-54. PubMed ID: 26070568
[TBL] [Abstract][Full Text] [Related]
50. Phosphorylation by the stress-activated MAPK Slt2 down-regulates the yeast TOR complex 2.
Leskoske KL; Roelants FM; Emmerstorfer-Augustin A; Augustin CM; Si EP; Hill JM; Thorner J
Genes Dev; 2018 Dec; 32(23-24):1576-1590. PubMed ID: 30478248
[No Abstract] [Full Text] [Related]
51. AKT Inhibition in Solid Tumors With AKT1 Mutations.
Hyman DM; Smyth LM; Donoghue MTA; Westin SN; Bedard PL; Dean EJ; Bando H; El-Khoueiry AB; Pérez-Fidalgo JA; Mita A; Schellens JHM; Chang MT; Reichel JB; Bouvier N; Selcuklu SD; Soumerai TE; Torrisi J; Erinjeri JP; Ambrose H; Barrett JC; Dougherty B; Foxley A; Lindemann JPO; McEwen R; Pass M; Schiavon G; Berger MF; Chandarlapaty S; Solit DB; Banerji U; Baselga J; Taylor BS
J Clin Oncol; 2017 Jul; 35(20):2251-2259. PubMed ID: 28489509
[TBL] [Abstract][Full Text] [Related]
52. Functions for Cdc42p BEM adaptors in regulating a differentiation-type MAP kinase pathway.
Basu S; González B; Li B; Kimble G; Kozminski KG; Cullen PJ
Mol Biol Cell; 2020 Mar; 31(6):491-510. PubMed ID: 31940256
[TBL] [Abstract][Full Text] [Related]
53. The interaction of Slt2 MAP kinase with Knr4 is necessary for signalling through the cell wall integrity pathway in Saccharomyces cerevisiae.
Martin-Yken H; Dagkessamanskaia A; Basmaji F; Lagorce A; Francois J
Mol Microbiol; 2003 Jul; 49(1):23-35. PubMed ID: 12823808
[TBL] [Abstract][Full Text] [Related]
54. The Rho1p exchange factor Rgf1p signals upstream from the Pmk1 mitogen-activated protein kinase pathway in fission yeast.
Garcia P; Tajadura V; Sanchez Y
Mol Biol Cell; 2009 Jan; 20(2):721-31. PubMed ID: 19037094
[TBL] [Abstract][Full Text] [Related]
55. Involvement of Saccharomyces cerevisiae Avo3p/Tsc11p in maintaining TOR complex 2 integrity and coupling to downstream signaling.
Ho HL; Lee HY; Liao HC; Chen MY
Eukaryot Cell; 2008 Aug; 7(8):1328-43. PubMed ID: 18552287
[TBL] [Abstract][Full Text] [Related]
56. Molecular mechanism of an oncogenic mutation that alters membrane targeting: Glu17Lys modifies the PIP lipid specificity of the AKT1 PH domain.
Landgraf KE; Pilling C; Falke JJ
Biochemistry; 2008 Nov; 47(47):12260-9. PubMed ID: 18954143
[TBL] [Abstract][Full Text] [Related]
57. Variants of the yeast MAPK Mpk1 are fully functional independently of activation loop phosphorylation.
Goshen-Lago T; Goldberg-Carp A; Melamed D; Darlyuk-Saadon I; Bai C; Ahn NG; Admon A; Engelberg D
Mol Biol Cell; 2016 Sep; 27(17):2771-83. PubMed ID: 27413009
[TBL] [Abstract][Full Text] [Related]
58. Characterization of P-Rex1 for its role in fMet-Leu-Phe-induced superoxide production in reconstituted COS(phox) cells.
Nie B; Cheng N; Dinauer MC; Ye RD
Cell Signal; 2010 May; 22(5):770-82. PubMed ID: 20074642
[TBL] [Abstract][Full Text] [Related]
59. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer.
Carpten JD; Faber AL; Horn C; Donoho GP; Briggs SL; Robbins CM; Hostetter G; Boguslawski S; Moses TY; Savage S; Uhlik M; Lin A; Du J; Qian YW; Zeckner DJ; Tucker-Kellogg G; Touchman J; Patel K; Mousses S; Bittner M; Schevitz R; Lai MH; Blanchard KL; Thomas JE
Nature; 2007 Jul; 448(7152):439-44. PubMed ID: 17611497
[TBL] [Abstract][Full Text] [Related]
60. Optimal chemotactic responses of leukemic T cells to stromal cell-derived factor-1 requires the activation of both class IA and IB phosphoinositide 3-kinases.
Curnock AP; Sotsios Y; Wright KL; Ward SG
J Immunol; 2003 Apr; 170(8):4021-30. PubMed ID: 12682230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
